It is not financial advice. This is my opinion. Please check yourselves and invest in the symbols that you think have a huge potential to reach the best results.
please leave us your opinion and reviews.🙏
Good Luck 👍
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs, and a related proprietary chemical reversal agent and Dex-IN.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍...
Setting up 3/4 alerts on this baby. Looks like it's ready to burst next few weeks last EPS was actually really good/financials actually don't look horrific. All black levels above are soft targets. Easy 80% gain possibly.
Price managed to close above the 20 EMA after testing the 9 ema to the down side and the .38 fib level ($1.46) on the upside.
MACD is crossing and the current price is nearly 27% bellow the POC line. I feel this is very oversold and will pop to recent highs.
Support $1.30 First target $2.12
see easy and self explanatory boxes on chart for Entry, Exit and Stop loss zones. Never chase any stock.
Not for any recommendation, Just an Idea. Like it >> Click 👍/comment, and follow.
Last week I also closed ( XBIO +26% in 32days; MYT +105% in 19 days)
BXRX looks like it has good potential. It is holding a tight consolidation area and seems to be getting ready soon. If we get the correct candles forming we can be in for a nice payday!!! Keep this www.tradingview.com on your watchlist for this week. if you see a green daily candle time to pounce on it.
Contextual immersion trading strategy idea.
Baudax Bio is a pharmaceutical company, develops and commercializes products for hospitals and other acute care settings.
The share price rose after good earnings. I see some preconditions the share price will continue growing.
The demand for shares of the company still looks higher than the supply.
These and other...
Baudax Bio, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for acute care settings. The company was founded in 2015 and is headquartered in Malvern, PA.